Regulation of microRNAs in coronary atherosclerotic plaque

Epigenomics. 2019 Sep;11(12):1387-1397. doi: 10.2217/epi-2019-0036. Epub 2019 Oct 9.

Abstract

Aim: Identification of microRNAs (miRNAs) associated with atherosclerosis may unravel novel therapeutic targets and biomarkers. We studied miRNAs differentially expressed between coronary atherosclerotic plaques (CAP) and healthy arteries. Materials & methods: Paired CAP and internal mammary arteries (IMA) were collected from 14 coronary artery disease patients. The miRNA profiles between diseased (CAP) and healthy (IMA) tissues were compared using microarrays and quantitative PCR. Results: Thirty-one miRNAs were differentially expressed between CAP and IMA. Among these, miR-486-5p showed a high level of regulation (12-fold), had predicted interactions with atherosclerosis-associated genes and correlated with triglyceride levels and arterial stenosis. Regulation of miR-486-5p was validated by PCR (p = 0.004). Conclusion: The miRNAs are regulated in the atherosclerotic plaque. We highlight miR-486-5p whose role in atherosclerosis requires further investigation.

Keywords: atherosclerosis; atherosclerotic plaque; coronary artery disease; microRNAs.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Case-Control Studies
  • Coronary Artery Disease / blood
  • Coronary Artery Disease / genetics*
  • Female
  • Gene Expression Profiling / methods*
  • Gene Regulatory Networks
  • Humans
  • Male
  • MicroRNAs / genetics*
  • Middle Aged
  • Oligonucleotide Array Sequence Analysis
  • Plaque, Atherosclerotic / blood
  • Plaque, Atherosclerotic / genetics*
  • Triglycerides / blood
  • Up-Regulation*

Substances

  • MIRN486 microRNA, human
  • MicroRNAs
  • Triglycerides